The present data, together, provide further evidence that Nosustrophine is an epinutraceutical bioproduct that regulates SIRT1 expression and the levels of histone H3 acetylation in an in vivo mouse model of AD. This evidence concerns the gene SIRT1 and Alzheimer disease.